This article was written by Follow The Value Portfolio specializes in building retirement portfolios and utilizes a fact-based research strategy to identify investments. This...
This article was written by B.A., M.A., University of Pennsylvania,; M.A., (Oxon.); Ph.D. Princeton University Currently CEO of WWS Swiss Financial Consulting SA Analyst’s...
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has delivered marginal growth over the past several years. A...
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases. Their groundbreaking RASP (reactive aldehyde species) pharmaceutical platform targets...
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid antibody drug Leqembi. For...